Pharmaceutical companies actively encouraged the hormone trend when they realized billions could be made by demonizing menopause and creating drugs to “cure” it. In the early 1960s
a major promotional campaign was launched claiming that “estrogen deficiencies” were the cause of most of the ills being felt by women before, during, and after menopause. Sales of products promising to replace the supposedly missing estrogen —called hormone replacement therapy (HRT)—skyrocketed. HRT had actually been in the works for some time. When doctors started to diagnose women with hormone issues, pharmaceutical companies suddenly had a use for their steroid-based lab experiment. They sent patients the message, “We see your pain, so we developed this revolutionary treatment for you.” In reality, they were just picking this as the perfect moment to release the products that had already been in development and hadn’t had an application until now.